OÜ PharmaTwo

Active Registry code 14436333 OÜ Tallinn Registered 26 Feb 2018

OÜ PharmaTwo is a OÜ based in Tallinn, registry code 14436333, status: active. Main activity: Retail sale of pharmaceutical products. According to EMTA, turnover for Q3 2026 was €612 906 with 11 employees.

Turnover

612 906 €

↑ 9.7% vs Q2 2026

State taxes

1 339 €

↓ 87.1% vs Q2 2026

Labour taxes

14 697 €

↑ 10.9% vs Q2 2026

Employees

+6 vs Q2 2026

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Retail trade · EMTAK 47

Turnover · Q3 2026 612 906 €

above 92% of companies

industry median 23 652 € · companies in the industry: 7 652
Labour taxes per employee 1 336 €

above 57% of companies

industry median 1 201 € · companies in the industry: 4 663
Revenue · 2025 2.8 mn €

above 98% of companies

industry median 16 974 € · companies in the industry: 13 500
Net profit margin · 2025 -1.3 %

above 32% of companies

industry median 1.3 % · companies in the industry: 9 480

Taxes and turnover

Q4 2023 – Q3 2026

Turnover, € thousand Q3 2026: 612 906 € · +9.7% vs Q2 2026 · industry median 23 652 € · above 92% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Labour taxes per employee, € Q3 2026: 1 336 € · −49.6% vs Q2 2026 · industry median 1 201 € · above 57% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q3 2026: 11 · +120.0% vs Q2 2026

State taxes, € Q3 2026: 1 339 € · −87.1% vs Q2 2026

Figures by quarter
Quarter	Turnover, €	State taxes, €	Labour taxes, €	Employees
Q3 2026	612 906	1 339	14 697	11
Q2 2026	558 825	10 391	13 251	5
Q1 2026	597 519	11 013	13 494	5
Q4 2025	568 487	15 574	13 692	3
Q3 2025	720 700	36 420	28 758	3
Q2 2025	768 751	13 137	22 416	13
Q1 2025	790 921	9 301	18 267	12
Q4 2024	863 142	13 061	17 004	13
Q3 2024	786 230	9 932	16 985	11
Q2 2024	780 966	7 550	14 811	11
Q1 2024	822 603	8 437	13 118	11
Q4 2023	966 839	3 313	11 758	12
Q3 2023	1 088 471	69 502	12 539	10
Q2 2023	787 064	2 699	11 470	9
Q1 2023	864 052	6 302	10 451	8
Q4 2022	847 444	4 394	10 919	7
Q3 2022	687 030	11 267	10 794	7
Q2 2022	724 710	—	6 356	6
Q1 2022	753 316	—	4 727	5

Labour taxes per employee per month

445 €

Turnover per employee in the quarter

55 719 €

Q3 2026 · calculated from EMTA data

Financials by year

2018 – 2025

Revenue, € thousand 2025: 2 767 414 € · −13.9% vs 2024 · industry median 16 974 € · above 98% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € thousand 2025: -35 011 € · −11.0% vs 2024 · industry median 0 € · above 2% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: -1.3 % · −0.3 pp vs the year before · industry median 1.3 % · above 32% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 396 227 € · −22.5% vs 2024

Equity, € thousand 2025: -612 449 € · −6.1% vs 2024

Employees 2025: 5 · +25.0% vs 2024 · industry median 2 · above 83% of the industry

Company
Industry median

Industry: Retail trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year	Revenue, €	Net profit, €	Labour costs, €	Assets, €	Equity, €	Employees
2025	2 767 414	-35 011	185 323	396 227	-612 449	5
2024	3 215 304	-31 534	164 184	511 340	-577 438	4
2023	3 696 086	20 535	122 046	584 106	-545 904	4
2022	3 095 514	900	90 571	971 591	-566 439	3
2021	2 664 553	86 296	40 518	862 515	-567 340	1
2020	2 289 832	-226 697	220 119	878 545	-653 635	12
2019	1 827 639	-300 598	345 470	847 743	-456 990	13
2018	—	—	—	—	—	13

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin

-1.3 %

Net profit / revenue

Return on assets (ROA)

-8.8 %

Net profit / assets

Equity ratio

-154.6 %

Equity / assets

Debt ratio

254.6 %

Liabilities / assets

Current ratio

0.39

Current assets / current liabilities

Revenue per employee

553 483 €

Revenue / average full-time employees

Labour cost per employee per month

3 089 €

Labour costs / employees / 12 months (incl. employer taxes)

Annual reports

PDFs from e-Äriregister

Annual reports
Year	Period	Filed	Report	Documents
2025	1 Jan 2025 – 31 Dec 2025	30 Jun 2026	Company’s own	e-Äriregister
2024	1 Jan 2024 – 31 Dec 2024	12 Jun 2025	Company’s own	e-Äriregister
2023	1 Jan 2023 – 31 Dec 2023	20 Jun 2024	Company’s own	e-Äriregister
2022	1 Jan 2022 – 31 Dec 2022	15 Jun 2023	Company’s own · audited	e-Äriregister
2021	1 Jan 2021 – 31 Dec 2021	21 Jun 2022	Company’s own · audited	e-Äriregister
2020	1 Jan 2020 – 31 Dec 2020	30 Jun 2021	Company’s own · audited	e-Äriregister
2019	1 Jan 2019 – 31 Dec 2019	18 Jan 2021	Company’s own · audited	e-Äriregister

Board

Lea Uustalu
Board member · since 27 Jan 2025
Nasdaq CSD SE
Keeper of the share register · since 1 Oct 2018

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Omanikukonto: LEA UUSTALU
Natural person · 2 500 €

100%

Beneficial owners

Lea Uustalu
Direct ownership · since 17 Feb 2025

Founders and other persons

osaühing SARMANDIA
Founder · 2 500 € · 23 Feb 2018

Activities (EMTAK)

47731Retail sale of pharmaceutical products Main

Rulings 9

All rulings (PDF)

Rulings
Number, date	Title	Deadline	State	Document
Ä 50088533 / M1 20 Jun 2025	Warning of compulsory dissolution: insufficient net assets	22 Dec 2025	Deficiencies eliminated 19 Dec 2025	PDF
Ä 50088533 / 8 27 Jan 2025	Amendment under Code of Civil Procedure § 595¹ (1)		In force 27 Jan 2025	PDF
Ä 50088533 / 7 27 Jan 2025	Amendment entry		In force 27 Jan 2025	PDF
Ä 50088533 / 6 3 Dec 2021	Amendment entry		In force 3 Dec 2021	PDF
Ä 50088533 / 5 11 Jan 2021	Amendment entry		In force 11 Jan 2021	PDF
Ä 50088533 / 4 1 Oct 2018	Amendment entry		In force 1 Oct 2018	PDF
Ä 50088533 / 3 20 Apr 2018	Amendment entry		In force 20 Apr 2018	PDF
Ä 50088533 / 2 27 Feb 2018	Amendment entry		In force 27 Feb 2018	PDF
Ä 50088533 26 Feb 2018	First entry		In force 26 Feb 2018	PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data